Inhibition of STAT3 or STAT5 signaling or genetic deletion of fatty acid translocation enzyme CD36 inhibited activation of oxidative metabolism and induction of immunosuppressive function in tumor-invasive MDSCs, leading to CD8+ T-cell-dependent tumor growth delay [54]. The gene discussed is STAT3; the disease is neoplasm.